1. Metabolic Enzyme/Protease
  2. Acyltransferase
  3. MGAT2-IN-7

MGAT2-IN-7 (compound 27Q) 是一种取代苯磺酰胺类化合物,同时也是单酰基甘油酰基转移酶 2 (MGAT2) 抑制剂。MGAT2-IN-7 可用于肥胖及代谢功能障碍相关脂肪性肝病 (MASLD) 的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

MGAT2-IN-7

MGAT2-IN-7 Chemical Structure

CAS No. : 3115123-06-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

查看 Acyltransferase 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

MGAT2-IN-7 (compound 27Q) is a substituted benzenesulfonamide compound and also a monoacylglycerol acyltransferase 2 (MGAT2) inhibitor. MGAT2-IN-7 is used for research on obesity and metabolic dysfunction-associated steatotic liver disease (MASLD)[1].

体外研究
(In Vitro)

MGAT2-IN-7 (compound 27Q) (0.1-10 μM; 45 h) 可在体外巯基荧光酶分析实验中强效抑制人单酰基甘油酰基转移酶 2,其 IC50 值<1 μM[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

MGAT2-IN-7 (27Q)(灌胃给药,每日 1 次,连续 7 天,剂量 15-50 mg/kg) 可在饮食诱导肥胖小鼠中引发剂量依赖性体重下降并减少食物摄入,其中 50 mg/kg (灌胃给药,每日 1 次,连续 7 天) 可使小鼠体重降低 6.8%[1]
MGAT2-IN-7 (27Q) (50 mg/kg;灌胃;每日一次;连续 22 天) 与 GLP-1 受体激动剂联用时,在饮食诱导肥胖小鼠中以 50 mg/kg (p.o., daily for 22 days) 的剂量可协同增强减重效果并减少食物摄入,其体重降低效应在第 17 天被测定[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6J (male, 16 weeks old, diet-induced obese)[1]
Dosage: 15 mg/kg; 50 mg/kg
Administration: p.o.; daily; 7 days
Result: Reduced average body weight by 1.39 g (3.6%) over 7 days, with 10% less 24-hour food intake and 9% less 7-day cumulative food.
Reduced average body weight by 2.5 g (6.8%) over 7 days, with 17% less 24-hour food intake and 20% less 7-day cumulative food.
Animal Model: C57BL/6J (male, diet-induced obese)[1]
Dosage: 50 mg/kg
Administration: p.o.; daily; 22 days
Result: Increased body weight reduction from -17.8% (tirzepatide alone) to -38% at 17 days and reduced cumulative food intake by 84% relative to vehicle controls (a 4-fold additional reduction over tirzepatide alone) when combined with maximum dose tirzepatide.
Increased body weight reduction from -32% (semaglutide alone) to -74.3% at 17 days and reduced cumulative food intake by 77% relative to vehicle controls (a 3.3-fold additional reduction over semaglutide alone) when combined with maximum dose semaglutide.
All differences were statistically significant.
分子量

629.65

Formula

C31H30F3N3O6S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
MGAT2-IN-7
目录号:
HY-181564
需求量: